EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial

Hugues Piloquet, Bénédicte Vrignaud, Florence Gillaizeau, Odile Capronnier, Kirsten Berding, Julia Günther, Christina Hecht, Christine Regimbart, GOLF III Study Group

The American Journal of Clinical Nutrition · 2024-05 · 119 (5) · 1259-1269

DOI: 10.1016/j.ajcnut.2024.03.005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2024-05. Verfasst von Hugues Piloquet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Chronic Diseases, University Hospital of Nantes, Nantes, France. Electronic address: hugues.piloquet@chu-nantes.fr. Hauptthemen laut MEDLINE: Infant Formula, Synbiotics, Respiratory Tract Infections, Feces. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Early life nutrition is crucial for the development of the gut microbiota that, in turn, plays an essential role in the maturation of the immune system and the prevention of infections. OBJECTIVES: The aim of this study was to investigate whether feeding synbiotic infants and follow-on formulas during the first year of life reduces the incidence rate (IR) of infectious diarrhea compared with standard formulas. Secondary endpoints included the IR of other infectious diseases as well as fecal milieu parameters. METHODS: In this double-blind, controlled trial, 460 healthy, 1-mo-old infants were randomly assigned to receive a synbiotic [galacto-oligosaccharides (GOS)/Limosilactobacillus fermentum CECT 5716] (IF, n = 230) or a control formula (CF, n = 230) until 12 mo of age. A reference group of breastfed infants (HM, n = 80) was included. Data on infections were recorded throughout the study period and stool samples were collected at 4 and 12 mo of age. RESULTS: IR of infectious diarrhea during the first year of life was 0.60 (CF), 0.56 (IF), and 0.29 (HM), with no statistically significant difference between groups. The IR of lower respiratory tract infections, 1 of the secondary endpoints, however, was lower in IF than in CF [0.79 compared with 1.01, IR ratio = 0.77 (0.60-1.00)]. Additionally, fecal pH was significantly lower at 4 mo (P < 0.0001), whereas secretory IgA was significantly higher at 12 mo of age (P = 0.015) in IF compared with CF. CONCLUSIONS: Although no difference is observed in the incidence of diarrhea, consumption of a synbiotic formula containing L. fermentum CECT5716 and GOS in infancy may reduce the incidence of lower respiratory tract infections and affect the immune system and fecal milieu. Additional research is warranted to further investigate the potential interaction of the gut-lung axis. This trial was registered at clinicaltrials.gov as NCT02221687.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant FormulaSynbioticsRespiratory Tract InfectionsFecesHumansInfantDouble-Blind MethodMaleFemaleOligosaccharidesInfant, NewbornLimosilactobacillus fermentumDiarrheaGastrointestinal DiseasesInfant Nutritional Physiological PhenomenaIncidence

Stichwörter der Autor:innen

GOSLimosilactobacillus fermentumformulagut microbiotagut–lung axisinfantinfectionsrespiratory tractsynbiotic

Substanzen

Oligosaccharides

Autor:innen und Institutionen

  • Department of Pediatric Chronic Diseases, University Hospital of Nantes, Nantes, France. Electronic address: hugues.piloquet@chu-nantes.fr.
  • Department of Pediatric Chronic Diseases, University Hospital of Nantes, Nantes, France.
  • Biofortis SAS, Saint Herblain, France.
  • HiPP GmbH & Co. Vertrieb KG, Pfaffenhofen, Germany.
  • Private Medical Office, Becon-les-Granits, France.

Zitieren

APA

Piloquet, H., Vrignaud, B., Gillaizeau, F., Capronnier, O., Berding, K., Günther, J., Hecht, C., Regimbart, C., & GOLF III Study Group (2024). Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial. The American Journal of Clinical Nutrition, 119(5), 1259-1269. https://doi.org/10.1016/j.ajcnut.2024.03.005

Vancouver

Piloquet H, Vrignaud B, Gillaizeau F, Capronnier O, Berding K, Günther J, et al. Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial. The American Journal of Clinical Nutrition. 2024;119(5):1259-1269. doi:10.1016/j.ajcnut.2024.03.005

BibTeX
@article{Piloquet2024,
  author = {Piloquet, Hugues and Vrignaud, Bénédicte and Gillaizeau, Florence and Capronnier, Odile and Berding, Kirsten and Günther, Julia and Hecht, Christina and Regimbart, Christine and GOLF III Study Group, GOLF III Study Group},
  title = {Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial},
  journal = {The American Journal of Clinical Nutrition},
  year = {2024},
  volume = {119},
  number = {5},
  pages = {1259--1269},
  doi = {10.1016/j.ajcnut.2024.03.005}
}
Kostenlos starten →